C'BON COSMETICS Co., Ltd. AI Stock Analysis
Want to see JP:4926 full AI Analyst Report?
C'BON COSMETICS Co., Ltd. (4926) AI Stock Analysis
C'BON COSMETICS Co., Ltd.
(TSE/TYO:4926)
C'BON COSMETICS earns a solid score primarily driven by its pristine, zero-debt balance sheet and a recent surge in free cash flow generation. Technical indicators show stable positive momentum as the stock trades above key moving averages. While valuation is reasonable with a moderate P/E, thin profit margins and historical inconsistency remain the primary risks to monitor.
C'BON COSMETICS Co., Ltd. (4926) vs. iShares MSCI Japan ETF (EWJ)
- Market Cap
- JPY 5.18B
- Dividend Yield
- 1.60%
- Average Volume (3M)
- 1,096
- Price to Earnings (P/E)
- 20.9
- Beta (1Y)
- 0.18
- Revenue Growth
- 1.51%
- EPS Growth
- -18.54%
- Country
- Japan
- Employees
- 717
- Sector
- Consumer Defensive
- Sector Strength
- 62
- Industry
- Household & Personal Products
C'BON COSMETICS Co., Ltd. Business Overview & Revenue Model
Company Description
C'BON COSMETICS Co.,Ltd. is engaged in the development and distribution of a diverse range of beauty products, encompassing conventional cosmetics, quasi-pharmaceuticals, and aesthetic devices. Its comprehensive product line includes essentials such...
How the Company Makes Money
The company makes money primarily by selling cosmetics and skincare-related products directly to consumers, leveraging a counseling/face-to-face sales approach where beauty consultants recommend products based on a customer’s skin condition and needs...
C'BON COSMETICS Co., Ltd. Financial Statement Overview
Summary
C'BON COSMETICS demonstrates a strong financial turnaround, highlighted by a debt-free balance sheet and impressive cash flow generation. While top-line growth and gross margins are stable, a thin 2.3% net profit margin indicates vulnerability to cost fluctuations.
Income Statement
72PositiveBalance Sheet
88Very PositiveCash Flow
78Positive| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 9.28B | 9.27B | 8.84B | 8.50B | 8.53B | 9.15B |
| Gross Profit | 7.10B | 7.03B | 6.74B | 6.40B | 6.34B | 7.10B |
| EBITDA | 465.25M | 454.62M | 292.59M | 168.63M | -92.22M | 329.61M |
| Net Income | 249.48M | 213.61M | 136.27M | -26.35M | -421.77M | 44.87M |
Balance Sheet | ||||||
| Total Assets | 8.43B | 8.60B | 8.60B | 8.81B | 8.84B | 9.56B |
| Cash, Cash Equivalents and Short-Term Investments | 2.69B | 3.02B | 2.65B | 3.63B | 3.98B | 2.80B |
| Total Debt | 0 | 596.00K | 0 | 4.24M | 13.27M | 22.30M |
| Total Liabilities | 2.64B | 2.91B | 2.89B | 3.15B | 3.13B | 3.36B |
| Stockholders Equity | 5.79B | 5.69B | 5.70B | 5.66B | 5.71B | 6.20B |
Cash Flow | ||||||
| Free Cash Flow | 0 | 553.88M | -926.52M | -301.11M | -693.60M | 330.15M |
| Operating Cash Flow | 0 | 763.10M | -43.16M | 278.19M | -81.47M | 433.37M |
| Investing Cash Flow | 0 | -159.99M | -849.16M | -581.94M | 1.35B | 44.91M |
| Financing Cash Flow | 0 | -240.69M | -90.22M | -31.20M | -91.29M | -6.73M |
C'BON COSMETICS Co., Ltd. Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:4926, the sentiment is Positive. The current price of 1247.00 is above the 20-day moving average (MA) of 1243.10, above the 50-day MA of 1238.65, and above the 200-day MA of 1241.63, indicating a bullish trend. The MACD of 2.00 indicates Negative momentum. The RSI at 60.65 is Neutral, neither overbought nor oversold. The STOCH value of 81.14 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for JP:4926.
C'BON COSMETICS Co., Ltd. Peers Comparison
Overall Rating
JP:492676Outperform
JP:491869Neutral
JP:492567Neutral
JP:493462Neutral
JP:492956Neutral
JP:493644Neutral
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| 76Outperform | JPY 5.34B | 20.94 | ― | 1.60% | 1.51% | -18.54% | |
| 69Neutral | JPY 2.85B | 14.82 | ― | 2.99% | -5.54% | -55.93% | |
| 67Neutral | JPY 6.25B | 10.83 | ― | 2.42% | -2.92% | -25.96% | |
| Sector * | 62Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% |
| 62Neutral | JPY 4.52B | 12.24 | ― | ― | -14.09% | -22.72% | |
| 56Neutral | JPY 5.89B | 36.88 | ― | 1.64% | -1.71% | 314.83% | |
| 44Neutral | JPY 6.63B | -13.33 | ― | 3.64% | -0.08% | -246.12% |
* Consumer Defensive Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| JP:4926 | C'BON COSMETICS Co., Ltd. | 1247.00 | 66.39 | 5.62% | |
| JP:4918 | Ivy Cosmetics Corporation | 502.00 | 187.02 | 59.38% | |
| JP:4925 | HABA Laboratories, Inc. | 1653.00 | 11.31 | 0.69% | |
| JP:4929 | ADJUVANT HOLDINGS CO., LTD. | 733.00 | -14.87 | -1.99% | |
| JP:4934 | Premier Anti-Aging Co., Ltd. | 518.00 | -185.00 | -26.32% | |
| JP:4936 | AXXZIA, Inc. | 275.00 | -129.94 | -32.09% |
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Nov 18, 2026
